STATINS AND THE RISK OF DIABETES MELLITUS
Randomized controlled trials have clearly demonstrated the efficacy of statins in reduction of serum low density lipoprotein cholesterol level by 25-50% from the baseline. Statins may increase the risk of diabetes mellitus (DM) in long-term therapy and use of high doses. Diabetogenic action is stati...
Kaydedildi:
| Yazar: | |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Столичная издательская компания
2015-09-01
|
| Seri Bilgileri: | Рациональная фармакотерапия в кардиологии |
| Konular: | |
| Online Erişim: | https://www.rpcardio.online/jour/article/view/111 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|